Skip to content

Company

Everest Medicines

Description

Headquarters
CN

Structure of Everest Medicines

Everest Medicines

Company

12 connections
UpstreamSupply and dependency3 of 4
OwnProducts and technology
DownstreamCustomers5 of 8
Relationship began2026
Everest MedicinesCompany · 12 connections
Layer 1

UpstreamSupply and dependency3

DownstreamCustomers5

OwnProducts and technology4

Place in the network

No. 98 of 15437top 1%

11 direct links

In a group of 61 closely linked entities, around

Weighted by public relations with evidence, recomputed daily.

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Everest Medicinesoperates in →United States
    Fact98%
    View evidence
    • MediaGDELT Global Knowledge Graph2026-10-10 13:45
      View source
    • MediaGDELT Global Knowledge Graph2026-10-09 12:45
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      expand Everest's presence in the United States
      View source
  • Everest Medicinesuses →mRNA
    Fact96%
    View evidence
    • MediaGDELT Global Knowledge Graph2026-10-10 13:45
      View source
    • MediaGDELT Global Knowledge Graph2026-10-09 12:45
      View source
    • MediaGDELT Global Knowledge Graph2026-10-09 12:45
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline
      View source
  • Everest Medicinesoperates in →oncology
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.
      View source
  • Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 10:13
      a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative pharmaceutical products
      View source
  • Everest Medicinesuses →Lipid nanoparticles
    Fact90%
    View evidence
    • MediaGDELT Global Knowledge Graph2026-10-09 12:45
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      Everest has established and optimized its proprietary LNP delivery system, with patent coverage including ionizable lipids and stealth lipids.
      View source
  • Everest Medicinesoperates in →autoimmune disease
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.
      View source
  • Everest Medicinesuses →mRNA technology
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 10:13
      Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
      View source
    • CompanyPR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and mRNA cancer vaccines
      View source
  • Everest Medicinesoperates in →Ophthalmology
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 10:13
      The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.
      View source

Showing 1 to 8 of 18

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-10 13:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-10 13:45
    View source
FactEvidence 3
operates inUnited States

expand Everest's presence in the United States

GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-10 13:45
    View source
  • MediaGDELT Global Knowledge Graph2026-10-09 12:45
    View source
  • CompanyPR Newswire news releases2026-10-09 10:13
    expand Everest's presence in the United States
    View source
FactEvidence 5
usesmRNA

Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.

GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-10 13:45
    View source
  • MediaGDELT Global Knowledge Graph2026-10-09 12:45
    View source
  • MediaGDELT Global Knowledge Graph2026-10-09 12:45
    View source
  • CompanyPR Newswire news releases2026-10-09 10:13
    Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
    View source
  • CompanyPR Newswire news releases2026-10-09 10:13
    Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline
    View source
FactEvidence 1

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-10 13:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-10 13:45
    View source
FactEvidence 1

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-09 16:15

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-09 16:15
    View source
FactEvidence 1

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-09 12:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-09 12:45
    View source

Showing 1 to 6 of 21

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance